[Drug therapy of bacterial infections in patients with kidney failure and hemodialysis].
Yamasaku
F
F
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents / Q000008:administration & dosage* / Q000009:adverse effects / Q000493:pharmacokinetics; D000995:Antitubercular Agents / Q000008:administration & dosage* / Q000009:adverse effects / Q000493:pharmacokinetics; D001424:Bacterial Infections / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D007668:Kidney / Q000378:metabolism; D007676:Kidney Failure, Chronic / Q000150:complications*; D007769:Lactams; D006435:Renal Dialysis / Q000009:adverse effects*
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D000995:Antitubercular Agents; D007769:Lactams